Evommune, Inc. (EVMN)
17.12
-0.40
(-2.28%)
USD |
NYSE |
Dec 31, 16:00
18.07
+0.95
(+5.55%)
Pre-Market: 20:00
Evommune Total Liabilities (Quarterly): 267.68M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BillionToOne, Inc. | 147.62M |
| PTC Therapeutics, Inc. | 2.799B |
| Spyre Therapeutics, Inc. | 49.50M |
| Denali Therapeutics, Inc. | 129.42M |
| Quince Therapeutics, Inc. | 108.84M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.54M |
| Shareholders Equity (Quarterly) | -183.14M |
| Debt to Equity Ratio | -1.408 |
| Current Ratio | 7.761 |